BRANFORD, Conn., Sept. 12, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it recently recorded the first commercial sale of its next generation FORE-SIGHT ELITE™ Cerebral Oximetry products. The Company received U.S. Food and Drug Administration (FDA) clearance for the ELITE in mid-April and began a controlled product introduction in August with select customers for evaluation purposes.
Help employers find you! Check out all the jobs and post your resume.
